NBRVF   $0.0002  0.0 Market Closed

Nabriva Therapeutics PLC
Total Cash 2.18M
totalCashPerShare 0.675
EBITDA -48.53M
Total Debt 540.00K
quickRatio 0.253
currentRatio 0.38
Total Revenue 29.56M
debtToEquity
Revenue/Share 9.611
ROA -0.92846
ROE -6.0221004
grossProfits
freeCashflow 10.81M
operatingCashflow -12.91M
earningsGrowth
revenueGrowth -0.756
grossMargins -0.61258
ebitdaMargins -1.64188
operatingMargins -5.36068
profitMargins -1.86264
enterpriseValue -1.64M
forwardPE
floatShares 3.04M
sharesOutstanding 3.23M
sharesShort 44.59K
sharesShortPriorMonth 35.34K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.06%
Short Ratio help_outline 8.58%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -5.052
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -55.05M
trailingEps -18.37%
forwardEps
enterpriseToEbitda 0.03
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2022
institutionsCount 2
lastUpdated Oct. 22, 2024, 11:19 p.m.